59
insulin pen
Worth a lookShows a thin review moat (36 avg reviews), but a failed launch gate (market size, growth, or returns) keeps it on the watch list.
Review moat
Incredible36.34avg incumbent reviews — the moat a new listing must climb
Quality gap
Incredible3.8★avg incumbent rating — lower means beatable quality
Returns
Incredible0.5%return rate — above 5% kills the launch gate
Avg price
Incredible€38.39avg listing price — sweet spot $15–$100
Price range
Great€6.84–€99.35cheapest to priciest tracked listing — scored on the share inside $15–$100
Brand share
Good68%top-5 brand share — brands hold most of the demand
Growth
Good+25.1%90-day search growth — must beat 0% to launch
Competition
Okay56%top-5 click share — leaders hold, buyers still browse
Conversion
Okay2.2%search→purchase rate — share of searches ending in a sale
Market size
Bad€42K€42K/yr · 50K searches